ProQR Therapeutics N.V. Ordinary Shares (PRQR)
ProQR Therapeutics N.V. is a biotechnology company focused on developing RNA-based medicines for genetic eye diseases and other rare genetic disorders. Founded in 2012 and based in the Netherlands, it specializes in designing therapies that target the root causes of these conditions, aiming to provide transformative treatments for patients with limited options.
Company News
ProQR Therapeutics reported its Q1 2025 financial results, highlighting progress in its Axiomer RNA editing pipeline, including the advancement of its lead program AX-0810 targeting NTCP for cholestatic diseases towards a CTA filing in Q2 2025. The company also strengthened its leadership team with new CFO and CMO appointments.
Regenxbio (RGNX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents. KeyCorp shares fell 5.4% to $13.10 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares jumped 92.8% to $0.1824 after falling 5% on Wednesday. Agrify Corporation (NASDAQ: AGFY) shares jumped 90% to $2.2401. Agrify said it entered into first Hydrocarbon Extraction Lab & Vertical Farming unit facility in California. Phunware, Inc. (NASDAQ: PHUN) shares jumped 67.9% to $0.2730. Phunware shares dipped 61% on Wednesday after the company announced pricing of a $7 million registered direct offering price at-the-market under Nasdaq rules. Celularity Inc. (NASDAQ: CELU) shares surged 43.4% to $0.2705 after falling more than 5% on Wednesday. Marpai, Inc. (NASDAQ: MRAI) shares jumped 34.4% to $1.1359 after declining over 8% on Wednesday. Marpai recently named John Powers as President. Akoustis Technologies, Inc. (NASDAQ: AKTS) gained 21.7% to $0.7698. Baijiayun Group Ltd (NASDAQ: RTC) gained 18.8% to $3.73. M.D.C. Holdings, Inc. (NYSE: MDC) rose 18.2% to $62.76 after the company announced it will be acquired by Sekisui House. CURO Group Holdings Corp. (NYSE: CURO) gained 15.7% to $0.8499. Lexeo Therapeutics, Inc. (NASDAQ: LXEO) rose 13% to $19.58. Aurora Technology Acquisition Corp. (NASDAQ: ATAK) gained 13% to $4.79. Acasti Pharma Inc. (NASDAQ: ACST) jumped 12.4% to $2.45. Dada Nexus Limited (NASDAQ: DADA) gained 11.8% to $1.6750. Dada Nexus recently announced that it discovered suspicious practices in an internal audit. Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) surged ...
The clinical-stage biotech released fourth-quarter and full-year earnings.
Analysts Say These Are Penny Stocks To Buy But Are They Worth The Risk? The post 5 Penny Stocks With Explosive Price Targets & Buy Ratings From Analysts appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.